| Name | Title | Contact Details |
|---|
Transgenomic is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events. Transgenomic has three complementary business divisions: Transgenomic Clinical Laboratories, which specializes in molecular diagnostics for cardiology, oncology, neurology, and mitochondrial disorders; Transgenomic Pharmacogenomic Services, a contract research laboratory that specializes in supporting all phases of pre-clinical and clinical trials for oncology drugs in development; and Transgenomic Diagnostic Tools, which produces equipment, reagents, and other consumables that empower clinical and research applications in molecular testing and cytogenetics. Transgenomic believes there is significant opportunity for continued growth across all three businesses by leveraging their synergistic capabilities, technologies, and expertise. The Company actively develops and acquires new technology and other intellectual property that strengthens its leadership in personalized medicine.
Surgical Principals is a Tacoma, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hillhouse Capital Management is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We`re Grassroots, a new cannabis company that`s all about living deeply. We started in Illinois and we`re growing nationally from the ground up. We care deeply, about our plants, our products and the people they serve.
Creating detection devices that increase productivity and save lives. Based in Boulder, CO the company integrates innovative technologies in various device platforms through strategic partnerships, licensing agreements and acquisitions. Currently we are pilot testing with international employers our first patented and proprietary device SOBRCheck, a non-invasive, touch-based identity verification and alcohol detection solution.